SynthesisBMC cancer2024

Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i.

Veronique Lambert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.